Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer

NCT00106002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast Neoplasms, Male
Carcinoma, Ductal

Interventions

DRUG: pemetrexed

Sponsor

Eli Lilly and Company